ELDN Earnings & Financial Statements
Eledon Pharmaceuticals, Inc.
$2.27
+$0.02(+0.89%)
28
Overall
60
Value
10
Tech
15
Quality
Market Cap
$182.84M
Volume
581.88K
52W Range
$1.29 - $4.49
Target Price
$9.50
ELDN earnings and financial statements: Eledon Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ELDN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$83.25M | -$70.58M | -$43.00M | -$88.43M | -$36.87M |
| EBITDA | -$45.58M | -$35.75M | -$116.16M | -$39.41M | -$36.67M |
| Net income | -$45.62M | -$36.18M | -$116.54M | -$87.97M | -$34.51M |
| EPS (diluted) | $-0.52 | $-0.75 | $-4.73 | $-6.16 | $-2.33 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $169.01M | $177.41M | $89.07M | $92.79M | $170.55M |
| Total liabilities | $32.23M | $59.27M | $81.86M | $8.61M | $6.55M |
| Shareholders’ equity | $81.08M | $62.45M | $7.21M | $84.18M | $164.00M |
| Cash and equivalents | $22.81M | $20.55M | $4.61M | $56.41M | $84.83M |
| Long-term debt | $283.0K | $640.0K | - | $383.0K | $400.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$62.34M | -$47.27M | -$39.53M | -$28.42M | -$28.91M |
| Free cash flow | -$62.34M | -$47.27M | -$39.53M | -$28.42M | -$28.91M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELDN | $2.27 | +0.9% | 581.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Eledon Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW